Evidence map›Paper›PMID 39747741›Full record

ArticleApplied biochemistry and biotechnology2025

Cloning, Heterologous Expression, and Biochemical Characterization of a Novel Glycoside Hydrolase 16 Family Enzyme for Biorefinery of Furcellaria lumbricalis.

Limin Ning, Yanshang Wei, Zilong Guo

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Limin NingCollege of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China. ninglimin@njucm.edu.cn.
Yanshang WeiCollege of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816, China.
Zilong GuoCollege of Food Science and Light Industry, Nanjing Tech University, Nanjing, 211816, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carrageenan has strong structural heterogeneity, resulting in the production of several hybridized forms in nature. Furcellaran is a typical hybrid type of carrageenan that includes both κ-carrageenan and β-carrageenan motifs in its structure. The discovery and characterization of a novel furcellaranase is of great significance for investigating and determining the structures of carrageenan. Herein, a new GH 16 enzyme CeFurA, with furcellaran and porphyran degrading activities, was cloned, and it included 350 amino acid residues and has a predicted theoretical molecular weight of 40.45 kDa. The enzyme displayed the highest biological activity (824.64 U/mg) on furcellaran at 35 °C and pH 9.0. Notably, CeFurA has excellent temperature stability throughout the wide 25 to 40 °C temperature range. It is useful and promising to efficient prepare hybrid bk-carrageenan oligosaccharides and elucidate the fine structure of the hybrid polysaccharide and oligosaccharides. TLC and ESI-MS indicate that CeFurA, as an endo-type enzyme, can specifically act on DA-Gβ1 → 4DA-G and DA-G4Sβ1 → 4DA-G4S glycosidic linkages within the furcellaran, producing disaccharides, tetrasaccharides, and hexasaccharides as the primary products. The CeFurA exhibited a sandwich-like structure according to structural modeling, which contains an embedded catalytic chamber formed by the β folded sheets placed in a reversing manner by acting on the internal DA-G4Sβ1 → 4DA-G4S glycosidic link. These exceptional properties make CeFurA a powerful tool for studying the heterogeneity of carrageenan structures and producing COS in the industry.

Indexed as

Bacterial ProteinsCloning, MolecularGlycoside HydrolasesCarrageenanEnzyme StabilityGene ExpressionSubstrate SpecificityTemperatureBacterial ProteinsCarrageenanGlycoside HydrolasesEnzyme characterizationFurcellaranFurcellaranaseHeterologous expression

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.